Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 11, 2004, Pages 1507-1512

  Bertaglia, Emanuele ^a,e   Bonso, Aldo ^b   Zoppo, Franco ^a   Proclemer, Alessandro ^c   Verlato, Roberto ^a   Corò, Leonardo ^a   Mantovan, Roberto ^d   Themistoclakis, Sakis ^b   Raviele, Antonio ^b   Pascotto, Pietro ^a  

^a Ospedale Civile   (Italy)

^b Ospedale Umberto I   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^d OSPEDALE CA FONCELLO   (Italy)

^e Ospedale Ca'Foncello ^*  (Italy)

Author keywords

Atrial fibrillation; Atrial flutter; Catheter ablation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE;

ADULT; AGED; ARTICLE; CATHETER ABLATION; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG INDUCED DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; IMAGE ANALYSIS; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CATHETER ABLATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPAFENONE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 9344271144     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00668.x     Document Type: Article

References (20)

1. Cosio FG, Lopez-Gil M, Giocolea A, et al. Radiofrequency ablation of the inferior cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol 1993; 71:705-709.
2. Fischer B, Haissaguerre M, Garrigues S, et al. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol 1995; 25:1365-1372.
3. Natale A, Newby KH, Pisanò E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofreqeuncy ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35:1898-1904.
4. Poty H, Saoudi N, Aziz AA, et al. Radiofrequency catheter ablation of type 1 atrial flutter: Prediction of late success by electrophysiological criteria. Circulation 1995; 92:1389-1392.
5. Shah DC, Takahashi A, Jais P, et al. Local electrogram-hased criteria of oavotricuspid isthmus block. J Cardiovasc Electrophysiol 1999; 10:662-669.
6. Anselme F, Savourè A, Cribier A, et al. Catheter ablation of typical atrial flutter. A randomized comparison of 2 methods for determining complete bidirectional isthmus block. Circulation 2001; 103:1434-1439.
7. Philippon F, Plumbe VJ, Epstein A, et al. The risk of atrial fibrillation following radiofrequency catheter ablation of common atrial flutter. Circulation 1995; 92:430-435.
8. Frey B, Kreiner B, Binder T, et al. Relation between left atrial size and secondary atrial arrhythmias after successful catheter ablation of common atrial flutter. PACE 1997; 20:2936-2942.
9. Tai CT, Chen SA, Chiang CE, et al. Long-term outcome of radiofrequency catheter ablation for typical atrial flutter; Risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 1998; 9:115-121.
10. Paydak H, Kail JG, Burke MC, et al. Atrial fibrillation after radiofrequency ablation of type I atrial flutter: Time to onset, determinants and clinical course. Circulation 1998; 98:315-322.
11. Nabar A, Rodriguez LM, Timmermans C, et al. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation. Observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation. Circulation 1999; 99:1441-1445.
12. Da Costa A, Romeyer C, Mourot S, et al. Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single-centre prospective study. Eur Heart J 2002; 23:498-506.
13. Huang DT, Monahan KM, Papageorgiou P, et al. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9:462-469.
14. Tai C, Chiang C, Lee S, et al. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol 1999; 10:1180-1187.
15. Schumacher B, Jung W, Lewalter T, et al. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999; 83:710-713.
16. Reithmann C, Hoffmann E, Spitzberger G, et al. Catheter ablation of atiial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 2000; 21:565-572.
17. Hsieh MH, Tai CT, Chiang CE, et al. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: A very long-term follow-up of 333 patients. J Interv Card Electrophysiol 2002; 7:225-231.
18. Schmieder S, Ndrepepa G, Dong J, et al. Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J 2003; 24:956-962.
19. Bertaglia E, Zoppo F, Bonso A, et al. Long-term follow-up of radiofrequency catheter ablation of atrial flutter: Clinical course and predictors of atrial fibrillation occurrence. Heart 2004; 90:59-63.
20. Reithmann C, Dorwarth U, Dugas M, et al. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter. Eur Heart J 2003; 24:1264-1272.